Table 1 Patients’ and tumor characteristics
Age N = 322 | ||
|---|---|---|
median | 66 years | |
range | 36 − 92 years | |
n | % | |
FIGO N = 320 | ||
IA | 104 | 32.5 % |
IB | 118 | 36.9 % |
II | 49 | 15.3 % |
IIIA | 13 | 4.1 % |
IIIB | 4 | 1.3 % |
IIIC | 29 | 9.1 % |
IVA | 2 | 0.6 % |
IVB | 1 | 0.3 % |
pT stage N = 320 | ||
T1 | 237 | 74.1 % |
T2 | 58 | 18.1 % |
T3 | 24 | 7.5 % |
T4 | 1 | 0.3 % |
Nodal status N = 320 | ||
N0 | 289 | 90.3 % |
N1 | 31 | 9.7 % |
Grading N = 322 | ||
G1 | 69 | 21.4 % |
G2 | 175 | 54.3 % |
G3 | 78 | 24.2 % |
LVSI N = 322 | ||
no LVSI | 269 | 83.5 % |
LVSI | 53 | 16.5 % |
Resection N = 322 | ||
R0 | 298 | 92.5 % |
R1 | 7 | 2.2 % |
R2 | 1 | 0.3 % |
RX | 16 | 5.0 % |
Metastases N = 320 | ||
M0 | 319 | 99.7 % |
M1 | 1 | 0.3 % |